Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Pediatric Endocrinology

Treatment and Managing Your Care

At a Glance

Aromatase deficiency treatment usually centers on individualized 17β-estradiol replacement. Doctors adjust the route and dose while monitoring bone age, bone density, hormone levels, physical development, medication safety, and fertility goals.

Treatment for aromatase deficiency is not a “one size fits all” approach. Because the condition is so rare, there are no universal clinical guidelines; instead, care is highly individualized and guided by experienced pediatric or adult endocrinologists [1][2]. The primary goal of treatment is estrogen replacement therapy, which aims to mimic the body’s natural hormone levels to support bone health, growth, and development.

The Approach: 17β-Estradiol

The foundation for treatment is replacing the missing estrogen, typically using 17β-estradiol [3][4]. This is the same form of estrogen the body would naturally produce if the aromatase enzyme were working correctly.

Treatment for 46,XX Individuals

For 46,XX individuals, the strategy is often to mirror the gradual hormone rise seen in typical female development.

  • Early Childhood: In some cases, very low doses of oral estradiol may be started early to support bone health and internal organ development [3].
  • Puberty: As an individual reaches pubertal age, the dose is gradually increased. The goal is to induce secondary sex characteristics (like breast development) and support the growth of the uterus and ovaries [3][5].
  • Biochemical Targets: Doctors monitor estradiol levels, bone age, and gonadotropins (FSH and LH). Dosing is highly individualized and guided by clinical development and your specific goals, rather than treating gonadotropins (FSH/LH) to a fixed target. Escalating estrogen solely to normalize FSH and LH is not recommended and should never be done without the prescribing team [3].
  • Long-term Cycles: Once the uterine lining has developed, doctors typically introduce a second hormone (progestogen) in a cyclic pattern to allow for regular withdrawal bleeding and protect the health of the uterus [5].

Treatment for 46,XY Individuals

In 46,XY individuals, the goals are often focused on the skeleton and metabolic health.

  • Bone Health and Height: A key goal for some is to “fuse” the epiphyses (growth plates). Without estrogen, these plates stay open, leading to continuous growth and weak bones [4][6]. Estrogen treatment can help stop further height gain and increase bone density, reducing the risk of fractures [7].
  • Delivery Methods: Many specialists use transdermal estradiol (patches or gels applied to the skin). Small case reports have shown that transdermal doses can help fuse growth plates, improve energy and libido, and normalize hormone levels within months, though this timeline and route are highly individualized [4][8].
  • Fertility Preservation: Fertility outcomes are uncertain. While some case reports suggest careful estrogen replacement can support bone health while preserving spermatogenesis (sperm production), exogenous estrogen can suppress sperm production [8]. It is strongly recommended to discuss fertility preservation, such as semen cryopreservation, with a reproductive specialist before starting treatment when developmentally appropriate.

Medication Safety

Like all medications, estrogen therapy has expected effects and potential risks that depend on the route, dose, and personal history (such as clotting problems, smoking, or migraines with aura).

  • Expected Effects: You may experience breast tenderness, nausea, headache, mood changes, or expected withdrawal bleeding. Discuss how to manage these with your care team. Never adjust your prescribed dose without consulting your endocrinology team, and follow instructions regarding missed doses.
  • Urgent Symptoms: Seek immediate emergency help if you develop sudden chest pain, shortness of breath, severe headache or vision changes, unilateral (one-sided) leg swelling, or jaundice.

Monitoring Success

Success isn’t measured by a single number, but by a combination of factors based on shared decisions about skeletal benefit and reproductive priorities:

  1. Skeletal Maturity: Regular X-rays to check “bone age” and ensure growth plates are responding to treatment [4][9].
  2. Bone Density: Using DXA scans to track improvements in bone strength [7].
  3. Hormone Balance: Blood tests to ensure estradiol is in a healthy range and that androgens (like testosterone) and gonadotropins (FSH/LH) are interpreted in context [3][8].
  4. Physical Well-being: Improvements in symptoms like bone pain, energy levels, and appropriate physical development.

The Importance of Specialized Care

Because aromatase deficiency is a lifelong condition, care must eventually transition from a pediatric endocrinologist to an adult specialist. This ensures that bone health and metabolic factors (like cholesterol and blood sugar) continue to be monitored throughout adulthood [2][10]. Your care team should ideally include experts in rare steroid disorders who understand the nuances of these hormone interactions.

Common questions in this guide

What is the main treatment for aromatase deficiency?
The main treatment is estrogen replacement with 17β-estradiol, the same form of estrogen the body would normally make. An endocrinologist adjusts the dose and delivery method to support bone health, growth, development, and the person’s treatment goals.
How does treatment differ for 46,XX and 46,XY individuals?
For 46,XX individuals, estrogen is often increased gradually to support pubertal development and growth of the uterus and ovaries; cyclic progestogen may be added later. For 46,XY individuals, treatment often emphasizes bone density, growth-plate fusion, metabolic health, and reproductive priorities.
How will doctors know whether estrogen treatment is working?
Doctors may follow bone age with X-rays, bone density with DXA scans, and blood levels of estradiol, testosterone, FSH, and LH. They also assess physical development, bone pain, energy, and overall well-being; no single hormone number determines success.
Should estradiol be taken as a pill or through the skin?
Both oral and transdermal estradiol may be used, and the best option depends on age, treatment goals, medical history, and the prescribing specialist’s judgment. Patients should not switch products or change doses without medical guidance.
Can estrogen treatment affect fertility in aromatase deficiency?
Fertility outcomes in aromatase deficiency are uncertain. Estrogen given from outside the body may suppress sperm production, so a 46,XY patient who may want biological children should discuss fertility preservation, such as semen freezing, with a reproductive specialist when appropriate.
Which estrogen side effects need urgent medical attention?
Breast tenderness, nausea, headache, mood changes, and withdrawal bleeding can occur with estrogen therapy. Get emergency help for sudden chest pain, shortness of breath, severe headache or vision changes, one-sided leg swelling, or jaundice.

Get notified when new evidence is published on Aromatase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Aromatase deficiency: A case series of 46, XX Chinese children and a systematic review of the literature.

    Fan L, Zhang B, Li L, Gong C

    Clinical endocrinology 2020; (93(6)):687-695 doi:10.1111/cen.14277.

    PMID: 32623730
  2. 2

    Bone Disease Associated with Inactivating Aromatase Mutations and its Management.

    Cavati G, Merlotti D, Cardamone P, et al.

    Calcified tissue international 2025; (116(1)):14 doi:10.1007/s00223-024-01330-0.

    PMID: 39751875
  3. 3

    Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.

    Burckhardt MA, Obmann V, Wolf R, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2015; (31(5)):349-54 doi:10.3109/09513590.2014.995619.

    PMID: 25585547
  4. 4

    Aromatase enzyme deficiency in an adult male patient and the effects of estrogen replacement therapy: a rare cause of tall stature.

    Imre E, Akçay S, Yavuz DG

    Hormones (Athens, Greece) 2025; (24(2)):525-532 doi:10.1007/s42000-025-00640-8.

    PMID: 40048086
  5. 5

    [A novel CYP19A1 variant causing aromatase deficiency in a family: case report and literature review].

    Ren WQ, Sun XF, Xue Y, et al.

    Zhonghua nei ke za zhi 2026; (65(9)):999-1004 doi:10.3760/cma.j.cn112138-20260210-00086.

    PMID: 42733266
  6. 6

    Aromatase deficiency in a tall man: Case report of two novel mutations and review of literature.

    Singhania P, Dash D, Dhar A, et al.

    Bone reports 2022; (17()):101642 doi:10.1016/j.bonr.2022.101642.

    PMID: 36504506
  7. 7

    Aromatase deficiency in a male patient - Case report and review of the literature.

    Miedlich SU, Karamooz N, Hammes SR

    Bone 2016; (93()):181-186 doi:10.1016/j.bone.2016.09.024.

    PMID: 27693882
  8. 8

    Congenital aromatase deficiency in an adult male: A case report of clinical course and symptom reversal with estrogen supplementation.

    Coady P, Walia A, Hernandez B, et al.

    Urology case reports 2026; (66()):103417 doi:10.1016/j.eucr.2026.103417.

    PMID: 41908849
  9. 9

    Aromatase deficiency caused by mutation of CYP19A1 gene: A case report.

    Li H, Fu S, Dai R, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2022; (47(6)):794-800 doi:10.11817/j.issn.1672-7347.2022.210401.

    PMID: 35837780
  10. 10

    A large cohort of disorders of sex development and their genetic characteristics: 6 novel mutations in known genes.

    Ata A, Özen S, Onay H, et al.

    European journal of medical genetics 2021; (64(3)):104154 doi:10.1016/j.ejmg.2021.104154.

    PMID: 33516834

This page is for informational purposes only and does not constitute medical advice or replace care from an endocrinologist. Treatment, monitoring, medication safety, and fertility decisions should be individualized with the patient’s care team.